Immunome (IMNM) Prepaid Assets (2019 - 2026)

Immunome has reported Prepaid Assets for 8 years, with the latest figure at $11.6 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 100.03% year-over-year to $11.6 million; the trailing twelve-month figure through Mar 2026 stood at $11.6 million (up 100.03% YoY), and the FY2025 full-year result was $7.3 million, up 80.75% from the prior year.
• Prepaid Assets for Q1 2026 stood at $11.6 million, up from $7.3 million in the prior quarter.
• The five-year high for Prepaid Assets was $11.6 million in Q1 2026, with the low at $71000.0 in Q1 2023.
• Historically, Prepaid Assets has averaged $4.4 million across 5 years, with a median of $3.9 million in 2024.
• Annual changes were most pronounced in 2023 — Prepaid Assets sank 95.01% — and 2024, when it surged 4998.59%.
• Immunome's Prepaid Assets stood at $2.3 million in 2022, then surged by 182.07% to $6.6 million in 2023, then slumped by 38.48% to $4.0 million in 2024, then surged by 80.75% to $7.3 million in 2025, then surged by 59.23% to $11.6 million in 2026.
• The last three Prepaid Assets figures came in at $11.6 million (Q1 2026), $7.3 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.